Home
News
Create
Screeners
Insights
Unjha Formulations
24.
71
-0.17
(-0.68%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.68%
1M
+5.19%
6M
+3.87%
1Y
-17.66%
5Y
+233.47%
View Company Insights
Latest news about Unjha Formulations
Unjha Formulations Reports Profit Turnaround in Q2 Despite Revenue Dip
Nov 11, 2025
Unjha Formulations Limited reported a profit of Rs 81.78 lacs in Q2 FY2026, a 109.75% increase from the previous quarter and a turnaround from a loss in Q2 FY2025. Net sales rose to Rs 428.53 lacs, up 18.57% quarter-on-quarter and 13.31% year-on-year. The company's total income increased by 19.63% to Rs 434.74 lacs, while total expenditure was effectively managed, decreasing 9.90% year-on-year. The EPS improved to 1.83, up from -0.25 in the same quarter last year. For the half-year, the company's net sales reached Rs 789.94 lacs with a profit of Rs 120.78 lacs, more than doubling from the previous year.
Unjha Formulations Appoints Siddharth Shah as Company Secretary and Compliance Officer
Oct 01, 2025
Unjha Formulations Reports Q1 Loss Amid Rising Expenses
Aug 06, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation